Ulf Lindström

1.9k total citations
64 papers, 1.1k citations indexed

About

Ulf Lindström is a scholar working on Rheumatology, Immunology and Hematology. According to data from OpenAlex, Ulf Lindström has authored 64 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Rheumatology, 22 papers in Immunology and 12 papers in Hematology. Recurrent topics in Ulf Lindström's work include Spondyloarthritis Studies and Treatments (37 papers), Rheumatoid Arthritis Research and Therapies (33 papers) and Psoriasis: Treatment and Pathogenesis (16 papers). Ulf Lindström is often cited by papers focused on Spondyloarthritis Studies and Treatments (37 papers), Rheumatoid Arthritis Research and Therapies (33 papers) and Psoriasis: Treatment and Pathogenesis (16 papers). Ulf Lindström collaborates with scholars based in Sweden, Denmark and Norway. Ulf Lindström's co-authors include Johan Askling, Helena Forsblad‐d’Elia, L. Jacobsson, Sofia Exarchou, Elisabeth Lie, Carl Turesson, Lars Erik Kristensen, Karin Lövgren Bengtsson, Mats Dehlin and Daniela Di Giuseppe and has published in prestigious journals such as Annals of the Rheumatic Diseases, The Annals of Thoracic Surgery and Lara D. Veeken.

In The Last Decade

Ulf Lindström

60 papers receiving 1.0k citations

Peers

Ulf Lindström
Alí Duarte‐García United States
Salih Pay Türkiye
Ana P. Lacerda United States
C. Michael Neuwelt United States
Richard K. Vehe United States
Alí Duarte‐García United States
Ulf Lindström
Citations per year, relative to Ulf Lindström Ulf Lindström (= 1×) peers Alí Duarte‐García

Countries citing papers authored by Ulf Lindström

Since Specialization
Citations

This map shows the geographic impact of Ulf Lindström's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulf Lindström with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulf Lindström more than expected).

Fields of papers citing papers by Ulf Lindström

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulf Lindström. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulf Lindström. The network helps show where Ulf Lindström may publish in the future.

Co-authorship network of co-authors of Ulf Lindström

This figure shows the co-authorship network connecting the top 25 collaborators of Ulf Lindström. A scholar is included among the top collaborators of Ulf Lindström based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulf Lindström. Ulf Lindström is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Exarchou, Sofia, Daniela Di Giuseppe, Eva Klingberg, et al.. (2024). Incidence of Clinically Diagnosed Psoriatic Arthritis in Sweden. The Journal of Rheumatology. 52(1). jrheum.2024–376. 1 indexed citations
2.
Exarchou, Sofia, Daniela Di Giuseppe, Eva Klingberg, et al.. (2023). Mortality in patients with psoriatic arthritis in Sweden: a nationwide, population-based cohort study. Annals of the Rheumatic Diseases. 83(4). 446–456. 9 indexed citations
3.
Exarchou, Sofia, Johan K. Wallman, Daniela Di Giuseppe, et al.. (2023). The National Prevalence of Clinically Diagnosed Psoriatic Arthritis in Sweden in 2017. The Journal of Rheumatology. 50(6). 781–788. 2 indexed citations
4.
Glintborg, Bente, Daniela Di Giuseppe, Johan K. Wallman, et al.. (2023). Uptake and effectiveness of newer biologic and targeted synthetic disease-modifying antirheumatic drugs in psoriatic arthritis: results from five Nordic biologics registries. Annals of the Rheumatic Diseases. 82(6). 820–828. 14 indexed citations
5.
Lindström, Ulf, Daniela Di Giuseppe, Sofia Exarchou, et al.. (2023). Methotrexate treatment in early psoriatic arthritis in comparison to rheumatoid arthritis: an observational nationwide study. RMD Open. 9(2). e002883–e002883. 8 indexed citations
6.
Wallman, Johan K., Eva Klingberg, Valgerður Sigurðardóttir, et al.. (2022). Validity of clinical psoriatic arthritis diagnoses made by rheumatologists in the Swedish National Patient Register. Scandinavian Journal of Rheumatology. 52(4). 374–384. 11 indexed citations
7.
Glintborg, Bente, Daniela Di Giuseppe, Johan K. Wallman, et al.. (2022). Is the risk of infection higher during treatment with secukinumab than with TNF inhibitors? An observational study from the Nordic countries. Lara D. Veeken. 62(2). 647–658. 10 indexed citations
8.
Frisell, Thomas, Hannah Bower, Eva Baecklund, et al.. (2022). POS0637 SAFETY OF b/tsDMARDs FOR RA AS USED IN CLINICAL PRACTICE - RESULTS FROM THE LAST DECADE OF THE ARTIS PROGRAM. Annals of the Rheumatic Diseases. 81. 587–588. 2 indexed citations
9.
Askling, Johan, Katerina Chatzidionysiou, Helena Forsblad‐d’Elia, et al.. (2021). OP0122 COMPARATIVE EFFECTIVENESS OF JAKI VERSUS BDMARDS; A NATIONWIDE STUDY IN RA. Annals of the Rheumatic Diseases. 80. 68–68. 2 indexed citations
10.
Bower, Hannah, Thomas Frisell, Daniela Di Giuseppe, et al.. (2021). POS1169 IMPACT OF THE COVID-19 PANDEMIC ON MORBIDITY AND MORTALITY AMONG SWEDISH PATIENTS WITH INFLAMMATORY JOINT DISEASES VERSUS THE GENERAL POPULATION. Annals of the Rheumatic Diseases. 80. 864–865. 1 indexed citations
11.
Giuseppe, Daniela Di, Ulf Lindström, Kalle Aaltonen, et al.. (2021). The occurrence of multiple treatment switches in axial spondyloarthritis. Results from five Nordic rheumatology registries. Lara D. Veeken. 61(9). 3647–3656. 5 indexed citations
12.
Lindström, Ulf, Bente Glintborg, Daniela Di Giuseppe, et al.. (2020). Comparison of treatment retention and response to secukinumab versus tumour necrosis factor inhibitors in psoriatic arthritis. Lara D. Veeken. 60(8). 3635–3645. 18 indexed citations
13.
Glintborg, Bente, Ulf Lindström, Daniela Di Giuseppe, et al.. (2020). One‐Year Treatment Outcomes of Secukinumab Versus Tumor Necrosis Factor Inhibitors in Spondyloarthritis: Results From Five Nordic Biologic Registries Including More Than 10,000 Treatment Courses. Arthritis Care & Research. 74(5). 748–758. 15 indexed citations
14.
Lindström, Ulf, et al.. (2019). Biological treatment of ankylosing spondylitis: a nationwide study of treatment trajectories on a patient level in clinical practice. Arthritis Research & Therapy. 21(1). 128–128. 21 indexed citations
16.
Lindström, Ulf, et al.. (2017). Sclerosing Aortic and Coronary Arteritis Due to IgG4-Related Disease. The Annals of Thoracic Surgery. 103(6). e487–e489. 11 indexed citations
17.
Lindström, Ulf, Ann Bremander, Emma Haglund, et al.. (2016). Back pain and health status in patients with clinically diagnosed ankylosing spondylitis, psoriatic arthritis and other spondyloarthritis: a cross-sectional population-based study. BMC Musculoskeletal Disorders. 17(1). 106–106. 20 indexed citations
18.
Exarchou, Sofia, Ulf Lindström, Björn Sundström, et al.. (2014). Validity of ankylosing spondylitis and spondyloarthritis diagnoses in the swedish national patient register. Clinical and Experimental Rheumatology. 32(5). 802–802. 4 indexed citations
19.
Lindström, Ulf. (1992). Euro-consent, Euro-contract, or Euro-coercion? : Scandinavian social democracy, the European impasse, and the abolition of things political. 6 indexed citations
20.
Berglund, Sten & Ulf Lindström. (1979). The Scandinavian Party System(s) In Transition (?) A Macro-Level Analysis. European Journal of Political Research. 7(2). 187–204. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026